GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427104. A total of 51 filers reported holding GENOCEA BIOSCIENCES INC in Q1 2017. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,138,000 | -14.3% | 218,100 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $1,328,000 | +47.7% | 218,100 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $899,000 | -16.4% | 218,100 | +3.8% | 0.00% | 0.0% |
| Q3 2016 | $1,076,000 | +23.8% | 210,100 | -1.0% | 0.00% | 0.0% |
| Q2 2016 | $869,000 | -47.8% | 212,122 | -1.4% | 0.00% | -50.0% |
| Q1 2016 | $1,666,000 | +45.5% | 215,223 | -1.0% | 0.00% | 0.0% |
| Q4 2015 | $1,145,000 | -23.0% | 217,346 | +0.1% | 0.00% | 0.0% |
| Q3 2015 | $1,487,000 | -48.9% | 217,039 | +2.4% | 0.00% | -50.0% |
| Q2 2015 | $2,910,000 | +27.4% | 211,924 | +10.0% | 0.00% | +33.3% |
| Q1 2015 | $2,284,000 | +113.9% | 192,612 | +26.2% | 0.00% | +50.0% |
| Q4 2014 | $1,068,000 | -22.5% | 152,612 | +0.2% | 0.00% | 0.0% |
| Q3 2014 | $1,378,000 | -39.5% | 152,312 | +25.5% | 0.00% | -50.0% |
| Q2 2014 | $2,276,000 | +3.1% | 121,412 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $2,208,000 | – | 121,412 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,968,606 | $10,276,000 | 10.63% |
| NORTHPOINTE CAPITAL LLC | 1,336,062 | $6,974,000 | 0.73% |
| AlphaMark Advisors, LLC | 304,886 | $1,592,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 490,000 | $2,558,000 | 0.44% |
| Rock Springs Capital Management LP | 480,000 | $2,506,000 | 0.13% |
| Birchview Capital, LP | 39,000 | $204,000 | 0.11% |
| Artemis Wealth Advisors, LLC | 18,188 | $47,518 | 0.04% |
| HAMILTON LANE ADVISORS LLC | 13,359 | $70,000 | 0.04% |
| AXA S.A. | 586,066 | $3,059,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 151,000 | $788,000 | 0.01% |